Ironwood Pharma (IRWD) Tops Q4 EPS by 4c

Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $94.2 thousand versus the consensus estimate of $86.2 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Playboy to buy back 16.6M shares from Fortress at $1.05 each
• Middleby board approves spin-off of food processing unit Midera